BASF sells chitosan biz to firm with eye on pharma
BASF has sold its chitosan biopolymers business to Norway-based Seagarden ASA continuing the divestiture of the non-core units it acquired as part of Cognis in 2010.
Archives for July 3, 2012
EXCLUSIVE QUOTES - Updated article
GSK speaks to IPT about the “mistakes” that led to $3bn criminal charges
GlaxoSmithKline (GSK) tells in-Pharmatechnologist.com that it was 'mistakes' made a decade ago that led to this week's $3bn worth of criminal charges.
News from Icon, NIH and Theradiag – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the changing faces in the world of pharmaceuticals, including news from Icon, NIH and Theradiag.
Argentina's CRO market set to boom, says report
Argentina’s clinical trial market will hit $76m (EUR60.4) by 2015 with growth driven by low costs, a good regulatory environment and large patient populations, according to a new study.
OLAW clarifies position on cost’s role in animal welfare after feedback
The US NIH has clarified its position on research animal welfare after its original statement raises concerns.